MedPath

Epuris

Approved
Approval ID

d6ba7a44-ca13-e001-e053-2995a90afe0c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 29, 2022

Manufacturers
FDA

Galephar Pharmaceutical Research Inc.

DUNS: 003551624

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Isotretinoin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66277-340
Product Classification
G
Generic Name
Isotretinoin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 29, 2022
FDA Product Classification

INGREDIENTS (5)

SOYBEAN OILInactive
Code: 241ATL177A
Classification: IACT
PEG-32 HYDROGENATED PALM GLYCERIDESInactive
Code: G6EP177239
Classification: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92
Classification: IACT
ISOTRETINOINActive
Quantity: 40 mg in 1 1
Code: EH28UP18IF
Classification: ACTIB
SORBITAN MONOOLEATEInactive
Code: 06XEA2VD56
Classification: IACT

Isotretinoin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66277-338
Product Classification
G
Generic Name
Isotretinoin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 29, 2022
FDA Product Classification

INGREDIENTS (5)

SOYBEAN OILInactive
Code: 241ATL177A
Classification: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92
Classification: IACT
ISOTRETINOINActive
Quantity: 20 mg in 1 1
Code: EH28UP18IF
Classification: ACTIB
SORBITAN MONOOLEATEInactive
Code: 06XEA2VD56
Classification: IACT
PEG-32 HYDROGENATED PALM GLYCERIDESInactive
Code: G6EP177239
Classification: IACT

Isotretinoin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66277-339
Product Classification
G
Generic Name
Isotretinoin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 29, 2022
FDA Product Classification

INGREDIENTS (5)

PROPYL GALLATEInactive
Code: 8D4SNN7V92
Classification: IACT
SOYBEAN OILInactive
Code: 241ATL177A
Classification: IACT
SORBITAN MONOOLEATEInactive
Code: 06XEA2VD56
Classification: IACT
PEG-32 HYDROGENATED PALM GLYCERIDESInactive
Code: G6EP177239
Classification: IACT
ISOTRETINOINActive
Quantity: 30 mg in 1 1
Code: EH28UP18IF
Classification: ACTIB

Isotretinoin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66277-337
Product Classification
G
Generic Name
Isotretinoin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 29, 2022
FDA Product Classification

INGREDIENTS (5)

SOYBEAN OILInactive
Code: 241ATL177A
Classification: IACT
SORBITAN MONOOLEATEInactive
Code: 06XEA2VD56
Classification: IACT
PROPYL GALLATEInactive
Code: 8D4SNN7V92
Classification: IACT
PEG-32 HYDROGENATED PALM GLYCERIDESInactive
Code: G6EP177239
Classification: IACT
ISOTRETINOINActive
Quantity: 10 mg in 1 1
Code: EH28UP18IF
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 8/1/2020

Epuris 40 mg Box of 3 blister cards

Epuris 40 mg Box of 3 blister cards

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Epuris - FDA Drug Approval Details